关注
Stephanie Shepheard
Stephanie Shepheard
在 flinders.edu.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
Biomarkers in motor neuron disease: a state of the art review
NS Verber, SR Shepheard, M Sassani, HE McDonough, SA Moore, ...
Frontiers in neurology 10, 291, 2019
1342019
Urinary p75ECD A prognostic, disease progression, and pharmacodynamic biomarker in ALS
SR Shepheard, J Wuu, M Cardoso, L Wiklendt, PG Dinning, T Chataway, ...
Neurology 88 (12), 1137-1143, 2017
1132017
Value of systematic genetic screening of patients with amyotrophic lateral sclerosis
SR Shepheard, MD Parker, J Cooper-Knock, NS Verber, L Tuddenham, ...
Journal of Neurology, Neurosurgery & Psychiatry 92 (5), 510-518, 2021
932021
The extracellular domain of neurotrophin receptor p75 as a candidate biomarker for amyotrophic lateral sclerosis
SR Shepheard, T Chataway, DW Schultz, RA Rush, ML Rogers
PLoS One 9 (1), e87398, 2014
752014
Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain
AG Thompson, E Gray, N Verber, Y Bobeva, V Lombardi, SR Shepheard, ...
Brain communications 4 (1), fcac029, 2022
532022
Multifaceted genes in amyotrophic lateral sclerosis-frontotemporal dementia
R Ranganathan, S Haque, K Coley, S Shepheard, J Cooper-Knock, ...
Frontiers in neuroscience 14, 684, 2020
512020
Inhibition of motor neuron death in vitro and in vivo by a p75 neurotrophin receptor intracellular domain fragment
D Matusica, F Alfonsi, BJ Turner, TJ Butler, SR Shepheard, ML Rogers, ...
Journal of Cell Science 129 (3), 517-530, 2016
312016
Removal of p75 Neurotrophin receptor expression from cholinergic basal forebrain neurons reduces amyloid-β plaque deposition and cognitive impairment in aged APP/PS1 mice
L Qian, MR Milne, S Shepheard, ML Rogers, R Medeiros, EJ Coulson
Molecular neurobiology 56, 4639-4652, 2019
282019
Urinary extracellular domain of neurotrophin receptor p75 as a biomarker for amyotrophic lateral sclerosis in a Chinese cohort
R Jia, S Shepheard, J Jin, F Hu, X Zhao, L Xue, L Xiang, H Qi, Q Qu, ...
Scientific Reports 7 (1), 5127, 2017
282017
Urinary neopterin: A novel biomarker of disease progression in amyotrophic lateral sclerosis
SR Shepheard, V Karnaros, B Benyamin, DW Schultz, M Dubowsky, ...
European journal of neurology 29 (4), 990-999, 2022
242022
Neuropathological characterization of a novel TANK binding kinase (TBK1) gene loss of function mutation associated with amyotrophic lateral sclerosis
M Weinreich, SR Shepheard, N Verber, M Wyles, PR Heath, JR Highley, ...
Neuropathology and Applied Neurobiology 46 (3), 279-291, 2020
162020
Biomarkers in motor neuron disease: a state of the art review. Front Neurol 10: 291
NS Verber, SR Shepheard, M Sassani, HE McDonough, SA Moore, ...
82019
Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations
ML Rogers, DW Schultz, V Karnaros, SR Shepheard
Brain Communications 5 (6), fcad287, 2023
52023
Urinary p75 neurotrophin receptor extracellular domain as a biomarker of symptomatic disease onset and progression
ML Rogers, J Wu, S Shepheard, T Chataway, D Schultz, P Anderson, ...
25th International Symposium on ALS/MND., 2014
22014
Neurotrophic Therapy for ALS/MND
M Dubowsky, SR Shepheard, ML Rogers
Handbook of Neurotoxicity, 1-37, 2021
12021
Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis
M Benatar, EA Macklin, A Malaspina, ML Rogers, E Hornstein, ...
eBioMedicine 108, 105323, 2024
2024
BRAIN COMMUNICATIONS
ML Rogers, DW Schultz, V Karnaros, SR Shepheard
2023
171 Urinary P75: a novel biomarker for motor neuron disease?
L Chapman, S Shepheard, N Verber, M Turner, A Malaspina, ML Rogers, ...
Journal of Neurology, Neurosurgery & Psychiatry 93 (9), e2, 2022
2022
BRAIN COMMUNICATIONS
JM Joers, IM Adanyeguh, DK Deelchand, DH Hutter, LE Eberly, I Iltis, ...
2022
BRAIN COMMUNICATIONS AIN COMMUNICATIONS
AG Thompson, E Gray, N Verber, Y Bobeva, V Lombardi, SR Shepheard, ...
2022
系统目前无法执行此操作,请稍后再试。
文章 1–20